SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274737-23-000101
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:54
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20231113.htm   iXBRL 8-K 28551
2 EX-99.1 q32023exagenearningspressr.htm EX-99.1 110074
6 image_0a.jpg GRAPHIC 29843
  Complete submission text file 0001274737-23-000101.txt   321104

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20231113.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20231113_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20231113_pre.xml EX-101.PRE 13041
8 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20231113_htm.xml XML 2988
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 231398611
SIC: 8071 Services-Medical Laboratories